iShares JPMorgan USD Emerging Markets Bond ETF vs JBS N.V. Class A Common Shares — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $91.23 (market cap $12.73B), while JBS N.V. Class A Common Shares trades at $13.05 (market cap $13.96B). The key difference: iShares JPMorgan USD Emerging Markets Bond ETF and JBS N.V. Class A Common Shares are close in size by market cap, and JBS N.V. Class A Common Shares pays a 10.31% dividend while iShares JPMorgan USD Emerging Markets Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares JPMorgan USD Emerging Markets Bond ETF for 50 Days and JBS N.V. Class A Common Shares for 0 Days on average.
| EMB | JBS | |
|---|---|---|
Market Cap | $12.73B | $13.96B |
Volume | 9,417,425 | 5,326,589 |
Sector | Fixed Income | Consumer Staples |
52-Week High | $97.74 | $18.42 |
52-Week Low | $90.14 | $10.86 |
Typical Hold Time | 50 Days | 0 Days |
Enterprise Value | — | $34.93B |
Dividend Yield | — | 10.31% |
Signals from Pluang's Aura AI — not financial advice
EMB trades at $91.26, up 0.2% over 24 hours, with technical indicators signaling a bearish trend and neutral oscillators. The stock faces resistance at $91 and $92, with support near $90. Recent dividend announcements for H2-26 suggest a focus on shareholder returns, but key valuation and profitability metrics are unavailable.
The outlook remains cautious due to bearish technical signals and limited fundamental data. Risks include market volatility and macroeconomic pressures from rising bond yields. Analyst sentiment is mixed, with some highlighting income potential but warning that significant price appreciation may be limited.
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →